Management of Mild Cognitive Impairment Patients With Extra Virgin Olive Oil - MICOIL (MICOIL)
Randomized, Double Blind, Placebo Controlled Prospective Study, to Evaluate the Effect of Freshly-Pressed Extra Virgin Olive Oil in the Disease's Progression in Patients Diagnosed With Mild Cognitive Impairment
Sponsor: Greek Alzheimer's Association and Related Disorders
Listed as NCT03362996, this PHASE2 trial focuses on Mild Cognitive Impairment and remains ongoing. Sponsored by Greek Alzheimer's Association and Related Disorders, it has been updated 6 times since 2016, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Unknown PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Unknown PHASE2
Status: Unknown Status → Unknown
-
Jan 2021 — Jul 2024 [monthly]
Unknown Status PHASE2
-
Feb 2020 — Jan 2021 [monthly]
Unknown Status PHASE2
Status: Recruiting → Unknown Status
-
Jun 2018 — Feb 2020 [monthly]
Recruiting PHASE2
▶ Show 1 earlier version
-
Dec 2017 — Jun 2018 [monthly]
Recruiting PHASE2
First recorded
Nov 2016
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Greek Alzheimer's Association and Related Disorders
For direct contact, visit the study record on ClinicalTrials.gov .